Meropenem therapy failure in Listeria monocytogenes infection

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 6, 2004, Pages 484-486

  Stepanovic S ^a   Lazarevic G ^b   Jesic M ^b   Kos R ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIINFECTIVE AGENT; CEFTRIAXONE; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

APLASTIC ANEMIA; ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DEATH; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; FEVER; HOSPITAL INFECTION; HUMAN; LABORATORY TEST; LISTERIA MONOCYTOGENES; LISTERIOSIS; MALE; PRIORITY JOURNAL; TREATMENT FAILURE;

EID: 3142552585     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1135-3     Document Type: Article

References (15)

1. Doganay M (2003) Listeriosis: clinical presentation. FEMS Immunol Med Microbiol 35:173-175
2. Hof H, Nichterlein T, Kretschmar M (1997) Management of listeriosis. Clin Microbiol Rev 10:345-357
3. Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM (2002) Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations. Antimicrob Agents Chemother 46:2095-2103
4. Marco F, Almela M, Nolla-Salas J, Coll P, Gasser I, Ferrer MD, de Simon M (2000) In vitro activities of 22 antimicrobial agents against Listeria monocytogenes strains isolated in Barcelona, Spain. The Collaborative Study Group of Listeriosis of Barcelona. Diagn Microbiol Infect Dis 38:259-261
5. Cometta A, Calandra T, Gaya H, Zinner SH, de Bock R, Del Favero A, Bucaneve G, Crokaert F, Kern WV, Klastersky J, Langenaeken I, Micozzi A, Padmos A, Paesmans M, Viscoli C, Glauser MP (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob Agents Chemother 40:1108-1115
6. Gaya H (1997) Carbapenems in febrile neutropenic patients. J Antimicrob Chemother 39:667-668
7. Immunocompromised Host Society (1990) The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel. J Infect Dis 161:397-401
8. Quagliarello VJ, Scheid WM (1997) Treatment of bacterial meningitis. N Engl J Med 336:708-716
9. Hof H (2003) Therapeutic options. FEMS Immunol Med Microbiol 35:203-205
10. Carryn S, Van Bambeke F, Mingeot-Leclercq MP, Tulkens PM (2003) Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. J Antimicrob Chemother 51:1051-1052
11. Vicente MF, Perez-Daz JC, Baquero F, Angel de Pedro M, Berenguer J (1990) Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for beta-lactams. Antimicrob Agents Chemother 34:539-542
12. Pierre J, Boisivon A, Gutmann L (1990) Alteration of PBP 3 entails resistance to imipenem in Listeria monocytogenes. Antimicrob Agents Chemother 34:1695-1698
13. Hof H, Waldenmeier G (1988) Therapy of experimental listeriosis-an evaluation of different antibiotics. Infection 16 (Suppl 2):171-174
14. Nairn K, Shepherd GL, Edwards JR (1995) Efficacy of meropenem in experimental meningitis. J Antimicrob Chemother 36(Suppl A):73-84
15. Weston VC, Punt J, Vloebeghs M, Watson AR, Ispahani P (1998) Listeria monocytogenes meningitis in a penicillin-allergic paediatric renal transplant patient. J Infect 37:77-78